The Role of β-Blockers as a Cornerstone of Cardiovascular Therapy
Open Access
- 1 December 2005
- journal article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 18 (12) , 165-168
Abstract
The β-adrenergic blockade as a therapeutic approach first emerged in the 1950s. During the past five decades, the total number of indications that haKeywords
This publication has 10 references indexed in Scilit:
- Cardioselective β-blockers in patients with reactive airway disease: a meta-analysisACC Current Journal Review, 2003
- Fresh Air and β-BlockadeAnnals of Internal Medicine, 2002
- Beta-Blockers after Myocardial Infarction: Do Benefits Ever Outweigh Risks in Asthma?Cardiology, 1999
- Clinical Relevance of Pharmacokinetic Differences Between Beta BlockersThe American Journal of Cardiology, 1997
- Beta blockers prevent cardiac death following a myocardial infarction: So why are so many infarct survivors discharged without beta blockers?The American Journal of Cardiology, 1996
- Physician use of beta-adrenergic blocking therapy: a changing perspectiveJACC, 1995
- Respiratory function in the elderly and the effects of beta blockadeCardiovascular Drugs and Therapy, 1991
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- Beta Adrenoceptor Antagonists and Respiratory DiseaseJournal of Cardiovascular Pharmacology, 1986
- BLOCKING OF INHIBITORY ADRENERGIC RECEPTORS BY A DICHLORO ANALOG OF ISOPROTERENOLThe Journal of Pharmacology and Experimental Therapeutics, 1958